Fidelity Investments
ARLZ

Fidelity Investments’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Fidelity Investments’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-266,469
Closed -$360K – 2705
2017
Q2 		$360K Sell
266,469
-7,000
-3% -$10.1K ﹤0.01% 2532
2017
Q1 		$585K Buy
273,469
+199
+0.1% +$748 ﹤0.01% 2516
2016
Q4 		$1.21M Hold
273,270
– – ﹤0.01% 2448
2016
Q3 		$1.32M Hold
273,270
– – ﹤0.01% 2424
2016
Q2 		$902K Hold
273,270
– – ﹤0.01% 2486
2016
Q1 		$970K Buy
+273,270
New +$1.41M ﹤0.01% 2482

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return

Fidelity Investments's ARLZ Position: Q3 2017 in Review

Fidelity Investments sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2017, closing a stake of 266,469 shares — an estimated $360K sold.

Fidelity Investments first reported a position in ARLZ in Q1 2016 and held it in 6 quarters. The position peaked at $1.32M in Q3 2016. 59 funds tracked by Wall St. Rank hold ARLZ as of Q3 2017.

  • Fidelity Investments reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2017 after selling out during the quarter.
  • Fidelity Investments sold 266,469 Aralez Pharmaceuticals Inc. shares in Q3 2017, an estimated $360K.
  • Fidelity Investments first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 6 quarters.
  • Fidelity Investments's Aralez Pharmaceuticals Inc. position peaked at $1.32M in Q3 2016.
  • 59 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2017.

Based on Fidelity Investments's 13F filing for Q3 2017, filed 13 Nov 2017.